Skip to content

Ironwood Pharmaceuticals

US · IRWD #3609 by market cap
3.75 +0.12 +3.31%
Live - 5344 symbols - heartbeat 318s ago · 2026-10-08 08:58
Pre-market 3.80 +1.27%
After-hours 3.54 -5.59%
Overnight 3.72 -0.80%
Market cap
619.65M
P/B
-3.83
EPS
0.15
Reader sentiment Are you bullish or bearish on IRWD?

Anonymous reader poll. Unscientific, not investment advice.

Recent news

  • Rating change
    Craig-Hallum Downgrades Ironwood Pharmaceuticals(IRWD.US) to Hold Rating, Announces Target Price $1.1
    Market Newswire · 2025/4/29
  • Wells Fargo Maintains Ironwood Pharmaceuticals(IRWD.US) With Hold Rating, Maintains Target Price $5
    Market Newswire · 2026/5/6
  • Rating change
    Craig-Hallum Maintains Ironwood Pharmaceuticals(IRWD.US) With Hold Rating
    Market Newswire · 2025/11/10
  • Rating change
    Citizens JMP Maintains Ironwood Pharmaceuticals(IRWD.US) With Buy Rating, Raises Target Price to $10
    Market Newswire · 2026/2/26
  • Rating change
    Craig-Hallum Downgrades Ironwood Pharmaceuticals(IRWD.US) to Hold Rating, Announces Target Price $1
    Market Newswire · 2025/4/17
  • Ironwood Pharmaceuticals(IRWD.US) Director Sells US$20.53 Million in Common Stock
    Market Newswire · 2026/3/18
  • Rating change
    Wells Fargo Maintains Ironwood Pharmaceuticals(IRWD.US) With Hold Rating, Maintains Target Price $1
    Market Newswire · 2025/5/1
  • Craig-Hallum Maintains Ironwood Pharmaceuticals(IRWD.US) With Buy Rating
    Market Newswire · 2026/7/16
  • Rating change
    Wells Fargo Maintains Ironwood Pharmaceuticals(IRWD.US) With Hold Rating, Raises Target Price to $3
    Market Newswire · 2025/11/12
  • Rating change
    Leerink Partners Maintains Ironwood Pharmaceuticals(IRWD.US) With Hold Rating, Maintains Target Price $1
    Market Newswire · 2025/4/16
  • Rating change
    Citizens JMP Upgrades Ironwood Pharmaceuticals(IRWD.US) to Buy Rating, Announces Target Price $8
    Market Newswire · 2026/1/5
  • Rating change
    Craig-Hallum Upgrades Ironwood Pharmaceuticals(IRWD.US) to Buy Rating
    Market Newswire · 2025/4/26
  • OneMedNet Collaborates With Inka Health To Provide Access To U.S. Real‐World Oncology Data Via IRWD Platform Powered By Palantir Foundry
    Benzinga · 2026/4/1
  • Rating change
    Jefferies Downgrades Ironwood Pharmaceuticals(IRWD.US) to Hold Rating, Cuts Target Price to $0.7
    Market Newswire · 2025/4/16
  • Rating change
    Wells Fargo Maintains Ironwood Pharmaceuticals(IRWD.US) With Hold Rating, Raises Target Price to $5
    Market Newswire · 2026/1/5
  • Rating change
    Craig-Hallum Maintains Ironwood Pharmaceuticals(IRWD.US) With Hold Rating, Announces Target Price $3.8
    Market Newswire · 2025/11/26
  • Analysts' Top Healthcare Picks: Ironwood Pharma (IRWD), Sionna Therapeutics, Inc. (SION)
    TipRanks · 2026/5/14
  • Rating change
    Craig-Hallum Maintains Ironwood Pharmaceuticals(IRWD.US) With Hold Rating, Announces Target Price $1.7
    Market Newswire · 2025/10/29
  • Rating change
    Craig-Hallum Upgrades Ironwood Pharmaceuticals(IRWD.US) to Buy Rating, Raises Target Price to $5.7
    Market Newswire · 2026/1/5
  • Rating change
    A Quick Look at Today's Ratings for Ironwood Pharmaceuticals(IRWD.US), With a Forecast Between $1 to $1
    Market Newswire · 2025/4/15

Headlines are aggregated automatically and are not independently verified or edited by our team.

Quote time 2026-10-08 08:58:11 · For reference only, not investment advice and not tailored to your situation.